Lisinopril PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Lisinopril PCD pharma franchise company offering 4 WHO-GMP certified formulations available in Tablets. We provide monopoly-based distribution rights to pharma entrepreneurs and distributors across India, backed by DCGI-approved quality and a reliable supply chain.
What is Lisinopril?
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that relaxes blood vessels to lower blood pressure and reduce the workload on the heart. It is a prescription-only medicine and should be used only under qualified medical supervision. Read the compound profile on PubChem.
Available Lisinopril Formulations
Cafoli Lifecare offers 4 Lisinopril formulations for franchise partners. Available forms: Tablets. Every batch is manufactured at WHO-GMP certified facilities and supplied with full regulatory documentation. Pricing is shared on request.
Therapeutic Applications
Lisinopril is used to treat hypertension and heart failure and to support recovery after a heart attack. It is prescribed mainly by cardiologists and general physicians.
Why Lisinopril is a High-Potential Molecule for Distributors
Hypertension affects a very large adult population in India and is managed with lifelong daily therapy, making Lisinopril a dependable, high-volume chronic-care molecule.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved products, attractive promotional inputs and dedicated marketing support to a growing network of 1000+ franchise partners across India. Our focus on quality and on-time supply makes us a preferred Lisinopril franchise partner.
References
- PubChem: Lisinopril
- PubMed research on Lisinopril
Our formulations of Lisinopril find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: